Skip To Content

Resources Library

Press Release

ACD/Labs Announces Version 2025 of Software on Its Spectrus® & Percepta® Platforms

Latest Spectrus applications offer deeper integrations, improvement to low code/no code automation, expansion of data import/export, and enhanced analytical data processing and interpretation. Percepta delivers improved prediction accuracy for several models.
Press Release

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

ACD/Labs is pleased to share that Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs. The acquisition will expand the breadth and depth of Revvity Signals’ solutions and bridge the gap between analytical data and actionable insights.
Press Release

ACD/Labs Announces Katalyst D2D® Software Release with Expanded Capabilities for Accelerated Pharmaceutical Development

Major update to Katalyst D2D will provide support for process scale-up and material characterization in pharmaceutical development.
Press Release

ACD/Labs and Covestro Announce Collaboration Delivering AI-Supported Solvent Selection at PhysChem Forum 2025

ACD/Labs and Covestro deliver AI-powered solvent recommendations integrated into Percepta, helping chemists expand solvent choices, streamline experiments, and access data-driven guidance for more efficient and sustainable chemical research.
Press Release

Redefining Pharmaceutical R&D Through AI and the Digitalized Physical DMTA Cycle

A new two-part white paper series from ACD/Labs examines how AI-enabled design-make-test-analyze (DMTA) cycles can overcome fragmented workflows in drug discovery and development.
Press Release

ACD/Labs and MilliporeSigma Expand Partnership

ACD/Labs is pleased to expand its partnership with MilliporeSigma, building on the 2023 collaboration that launched the first digital reference material (dRM) platform, ChemisTwin™ Platform.
Press Release

ACD/Labs Releases State-of-the-Industry Report Highlighting Trends in Chemical Structure Elucidation & Verification in Chemical R&D

Analytical groups are trying to support an increasing volume of requests without expanded capacity or staffing. This 2025 report highlights an upward trend in sample handling automation, automated data processing, and prediction (AI/ML-based) model development. Furthermore, stakeholders report that productivity initiatives must ensure expected levels of data integrity, quality, and result accuracy.
Press Release

ACD/Labs Releases v2024 of Modeling Platform Percepta® to Support Pharmaceutical and Chemical R&D at the PhysChem Forum

Version 2024 of Percepta delivers substantial expansions to the training sets and algorithms, improving prediction accuracy for pKa and logP calculators, and a range of ADME and toxicity endpoints. This update also increases coverage of chemical space occupied by new therapeutic modalities such as proteolysis targeting chimeras (PROTACs).